Clinical Trials Directory

Trials / Terminated

TerminatedNCT00705913

Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna

A Randomized Study to Compare Sizing, Implant Techniques and Hemodynamic Performance Between the Mitroflow and the Carpentier-Edwards Magna Pericardial Tissue Valves in the Aortic Position

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
368 (actual)
Sponsor
Sorin Group USA, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.

Detailed description

Comparisons of valve types are often made according to labeled valve sizes. There is growing evidence that in the majority of cases the actual sizer and valve dimensions vary from the labeled diameters, which may not be related to any hemodynamically meaningful dimension. The disagreement between the true valve dimensions and the labeled valve size may render comparisons based on labeled size meaningless

Conditions

Interventions

TypeNameDescription
DEVICEMitroflow Aortic Pericardial Heart Valve (CarboMedics)Study to compare sizing, implant techniques and hemodynamics of the Mitroflow Pericardial valve as compared to the Edwards Magna valve
DEVICECarpentier-Edwards Magna Tissue ValveStudy to compare sizing, implant techniques and hemodynamics of the Mitroflow Valve as compared to the Edwards Magna valve

Timeline

Start date
2008-06-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2008-06-27
Last updated
2012-01-09

Locations

12 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT00705913. Inclusion in this directory is not an endorsement.